Results
1 -
10 of
12Microtubule Targeting Agents and the Tumor Vasculature, The Role of Microtubules in Cell Biology, Neurobiology, and Oncology Vascular Disruptive Agents in Combination with Radiotherapy, Vascular Disruptive Agents for the Treatment of Cancer Combination Therapy with Chemotherapy and VDAs, Vascular Disruptive Agents for the Treatment of Cancer Vascular Disrupting Agents in Cancer Therapy, Tumor Angiogenesis An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3??weeks in Japanese patients with advanced solid tumors, Cancer Chemotherapy and Pharmacology Antitumor and antivascular effects of AC-7700, a combretastatin A-4 derivative, against rat liver cancer, International Journal of Clinical Oncology Plant-derived vascular disrupting agents: compounds, actions, and clinical trials, Phytochemistry Reviews Synthesis, Crystal Structure and Cytotoxic Properties of Nitrocombretastatins (E)- and (Z)-5-(4-Methoxy-3-nitrostyryl)-1,2,3-trimethoxybenzene, Journal of Chemical Crystallography Novel water-soluble anticancer agents derived from 4-arylcoumarins, Russian Chemical Bulletin Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism, Cancer and Metastasis Reviews